800-872-2273

Clinical Trials and Studies

Study Title	Principal Investigator
A Multicenter, Open-Label, Long-Term Safety Extension of Phase II Studies ABE4869g and ABE4955g in Patients With Mild to Moderate Alzheimer's Disease Completed \| Alzheimer's Disease \| Multisite View full trial information >>
<< < 33 34 35 36 37 ... 39 >>